Global Sentinel, Other

Oxford AstraZeneca Covid vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientist

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The Covid vaccine developed in the UK by Oxford University and AstraZeneca can protect 70.4% of people from becoming ill and – in a surprise result – up to 90% if a lower first dose is used, results from the final trial show.

The Oxford vaccine is the third to produce efficacy results, following Pfizer/BioNTech and Moderna whose vaccines were made with a different technology. Both of those reported almost 95% efficacy and Pfizer has applied for a licence in the US and UK.